FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2054222787> ?p ?o ?g. }

• W2054222787 endingPage "40059" @default.
• W2054222787 startingPage "40050" @default.
• W2054222787 abstract "The calcium-regulated phosphatase calcineurin intersects with both calcium and cAMP-mediated signaling pathways in the pancreatic β-cell. Pharmacologic calcineurin inhibition, necessary to prevent rejection in the setting of organ transplantation, is associated with post-transplant β-cell failure. We sought to determine the effect of calcineurin inhibition on β-cell replication and survival in rodents and in isolated human islets. Further, we assessed whether the GLP-1 receptor agonist and cAMP stimulus, exendin-4 (Ex-4), could rescue β-cell replication and survival following calcineurin inhibition. Following treatment with the calcineurin inhibitor tacrolimus, human β-cell apoptosis was significantly increased. Although we detected no human β-cell replication, tacrolimus significantly decreased rodent β-cell replication. Ex-4 nearly normalized both human β-cell survival and rodent β-cell replication when co-administered with tacrolimus. We found that tacrolimus decreased Akt phosphorylation, suggesting that calcineurin could regulate replication and survival via the PI3K/Akt pathway. We identify insulin receptor substrate-2 (Irs2), a known cAMP-responsive element-binding protein target and upstream regulator of the PI3K/Akt pathway, as a novel calcineurin target in β-cells. Irs2 mRNA and protein are decreased by calcineurin inhibition in both rodent and human islets. The effect of calcineurin on Irs2 expression is mediated at least in part through the nuclear factor of activated T-cells (NFAT), as NFAT occupied the Irs2 promoter in a calcineurin-sensitive manner. Ex-4 restored Irs2 expression in tacrolimus-treated rodent and human islets nearly to baseline. These findings reveal calcineurin as a regulator of human β-cell survival in part through regulation of Irs2, with implications for the pathogenesis and treatment of diabetes following organ transplantation. The calcium-regulated phosphatase calcineurin intersects with both calcium and cAMP-mediated signaling pathways in the pancreatic β-cell. Pharmacologic calcineurin inhibition, necessary to prevent rejection in the setting of organ transplantation, is associated with post-transplant β-cell failure. We sought to determine the effect of calcineurin inhibition on β-cell replication and survival in rodents and in isolated human islets. Further, we assessed whether the GLP-1 receptor agonist and cAMP stimulus, exendin-4 (Ex-4), could rescue β-cell replication and survival following calcineurin inhibition. Following treatment with the calcineurin inhibitor tacrolimus, human β-cell apoptosis was significantly increased. Although we detected no human β-cell replication, tacrolimus significantly decreased rodent β-cell replication. Ex-4 nearly normalized both human β-cell survival and rodent β-cell replication when co-administered with tacrolimus. We found that tacrolimus decreased Akt phosphorylation, suggesting that calcineurin could regulate replication and survival via the PI3K/Akt pathway. We identify insulin receptor substrate-2 (Irs2), a known cAMP-responsive element-binding protein target and upstream regulator of the PI3K/Akt pathway, as a novel calcineurin target in β-cells. Irs2 mRNA and protein are decreased by calcineurin inhibition in both rodent and human islets. The effect of calcineurin on Irs2 expression is mediated at least in part through the nuclear factor of activated T-cells (NFAT), as NFAT occupied the Irs2 promoter in a calcineurin-sensitive manner. Ex-4 restored Irs2 expression in tacrolimus-treated rodent and human islets nearly to baseline. These findings reveal calcineurin as a regulator of human β-cell survival in part through regulation of Irs2, with implications for the pathogenesis and treatment of diabetes following organ transplantation." @default.
• W2054222787 created "2016-06-24" @default.
• W2054222787 creator A5004648124 @default.
• W2054222787 creator A5013723938 @default.
• W2054222787 creator A5013876679 @default.
• W2054222787 creator A5034021483 @default.
• W2054222787 creator A5044933279 @default.
• W2054222787 creator A5047561079 @default.
• W2054222787 creator A5048833820 @default.
• W2054222787 creator A5051617679 @default.
• W2054222787 creator A5052338741 @default.
• W2054222787 creator A5062653983 @default.
• W2054222787 creator A5087837146 @default.
• W2054222787 date "2010-12-01" @default.
• W2054222787 modified "2023-10-16" @default.
• W2054222787 title "Calcineurin Signaling Regulates Human Islet β-Cell Survival" @default.
• W2054222787 cites W1520222296 @default.
• W2054222787 cites W1556383867 @default.
• W2054222787 cites W1569503463 @default.
• W2054222787 cites W1697523131 @default.
• W2054222787 cites W1794038664 @default.
• W2054222787 cites W1969337837 @default.
• W2054222787 cites W1969459168 @default.
• W2054222787 cites W1977589132 @default.
• W2054222787 cites W1979270142 @default.
• W2054222787 cites W1980274924 @default.
• W2054222787 cites W1983513002 @default.
• W2054222787 cites W1996046875 @default.
• W2054222787 cites W2004466285 @default.
• W2054222787 cites W2005195518 @default.
• W2054222787 cites W2009184816 @default.
• W2054222787 cites W2009661936 @default.
• W2054222787 cites W2015001567 @default.
• W2054222787 cites W2015413597 @default.
• W2054222787 cites W2016730049 @default.
• W2054222787 cites W2027317575 @default.
• W2054222787 cites W2032322539 @default.
• W2054222787 cites W2040143421 @default.
• W2054222787 cites W2053073281 @default.
• W2054222787 cites W2054821923 @default.
• W2054222787 cites W2054851392 @default.
• W2054222787 cites W2059576139 @default.
• W2054222787 cites W2063970883 @default.
• W2054222787 cites W2064438699 @default.
• W2054222787 cites W2068240122 @default.
• W2054222787 cites W2074528335 @default.
• W2054222787 cites W2081211041 @default.
• W2054222787 cites W2082763759 @default.
• W2054222787 cites W2086107539 @default.
• W2054222787 cites W2087175644 @default.
• W2054222787 cites W2088359631 @default.
• W2054222787 cites W2092983614 @default.
• W2054222787 cites W2095765492 @default.
• W2054222787 cites W2097573911 @default.
• W2054222787 cites W2106709311 @default.
• W2054222787 cites W2111404063 @default.
• W2054222787 cites W2114594243 @default.
• W2054222787 cites W2115240185 @default.
• W2054222787 cites W2127238864 @default.
• W2054222787 cites W2127791191 @default.
• W2054222787 cites W2131426434 @default.
• W2054222787 cites W2131840335 @default.
• W2054222787 cites W2132051907 @default.
• W2054222787 cites W2135435990 @default.
• W2054222787 cites W2136564386 @default.
• W2054222787 cites W2139231656 @default.
• W2054222787 cites W2140439371 @default.
• W2054222787 cites W2142228286 @default.
• W2054222787 cites W2142270833 @default.
• W2054222787 cites W2143722971 @default.
• W2054222787 cites W2144579086 @default.
• W2054222787 cites W2145039418 @default.
• W2054222787 cites W2148147368 @default.
• W2054222787 cites W2148785089 @default.
• W2054222787 cites W2152794772 @default.
• W2054222787 cites W2153134360 @default.
• W2054222787 cites W2161163854 @default.
• W2054222787 cites W2162426318 @default.
• W2054222787 cites W2163652885 @default.
• W2054222787 cites W2165991181 @default.
• W2054222787 cites W2166542012 @default.
• W2054222787 cites W2184203459 @default.
• W2054222787 cites W2792263124 @default.
• W2054222787 cites W4236562345 @default.
• W2054222787 cites W4255925138 @default.
• W2054222787 doi "https://doi.org/10.1074/jbc.m110.154955" @default.
• W2054222787 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3000987" @default.
• W2054222787 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20943662" @default.
• W2054222787 hasPublicationYear "2010" @default.
• W2054222787 type Work @default.
• W2054222787 sameAs 2054222787 @default.
• W2054222787 citedByCount "132" @default.
• W2054222787 countsByYear W20542227872012 @default.
• W2054222787 countsByYear W20542227872013 @default.
• W2054222787 countsByYear W20542227872014 @default.
• W2054222787 countsByYear W20542227872015 @default.
• W2054222787 countsByYear W20542227872016 @default.
• W2054222787 countsByYear W20542227872017 @default.

• next